Peter Holme Jensen
Founder bij Silico Pharma ApS
Vermogen: 987 102 $ op 31-03-2024
Profiel
Peter Holme Jensen is the founder of ENKAM Pharmaceuticals A (founded in 2000) and Aquaporin A (founded in 2005).
At Aquaporin A, he held the title of Chief Innovation Officer from 2022 to 2024.
Dr. Jensen is also the founder of Silico Pharma ApS.
Currently, he holds the position of Director at InnovationsFonden and Aquaporin Space Alliance ApS.
Dr. Jensen holds a doctorate degree from the University of Copenhagen and a graduate degree from the University of Southern Denmark.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AQUAPORIN A/S
1.92% | 31-12-2022 | 210 659 ( 1.92% ) | 987 102 $ | 31-03-2024 |
Actieve functies van Peter Holme Jensen
| Bedrijven | Functie | Begin |
|---|---|---|
| Silico Pharma ApS | Founder | 14-04-2010 |
Aquaporin Space Alliance ApS
 Aquaporin Space Alliance ApS Aerospace & DefenseElectronic Technology Aquaporin Space Alliance ApS operates as joint venture that commercializes the Aquaporin Inside technology in space applications and space programs together with European and US-based entities. The firm develops water recycling and filtration solutions. The company was founded in May 2013 and is headquartered in Odense, Denmark. | Director/Board Member | - |
InnovationsFonden
 InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | Director/Board Member | - |
Eerdere bekende functies van Peter Holme Jensen
| Bedrijven | Functie | Einde |
|---|---|---|
| AQUAPORIN A/S | Chief Executive Officer | 01-01-2022 |
ENKAM Pharmaceuticals A/S
 ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | Founder | 09-12-2008 |
Opleiding van Peter Holme Jensen
| University of Copenhagen | Doctorate Degree |
| University of Southern Denmark | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AQUAPORIN A/S | Producer Manufacturing |
| Bedrijven in privébezit | 4 |
|---|---|
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Silico Pharma ApS | |
InnovationsFonden
InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | Finance |
Aquaporin Space Alliance ApS
Aquaporin Space Alliance ApS Aerospace & DefenseElectronic Technology Aquaporin Space Alliance ApS operates as joint venture that commercializes the Aquaporin Inside technology in space applications and space programs together with European and US-based entities. The firm develops water recycling and filtration solutions. The company was founded in May 2013 and is headquartered in Odense, Denmark. | Electronic Technology |
